As part of Evidera’s Market Access Consulting team in London, Tim’s experience is in supporting clients in their development of global pricing, reimbursement, and market access strategy. He brings 15+ years’ global pricing and market access consultancy expertise, during which he has led over 1,500 global research projects. Tim has worked in all major disease areas and has extensive experience in rare and orphan conditions. Having chaired over 100 global advisory boards (pricing and reimbursement, methodological economics, and clinical), he has developed skills as a highly experienced global meeting chairman. He has close relationships with payer decision makers in US and 5EU markets.
In addition to his consultancy experience, Tim also brings 12 years pricing and reimbursement experience gained from global, European, and UK pricing, reimbursement, and health economics positions within the pharmaceutical sector. Prior to joining Evidera, Tim was global pricing and market access director with responsibility for CRESTOR, Seroquel and the emerging CV, inflammation, and oncology portfolios at AstraZeneca. Other positions he has held in the industry include head of health economics and outcomes research at Janssen-Cilag UK, and European pricing and reimbursement for Botox at Allergan.
Tim received a BA in economics joint with public administration and has a post-graduate diploma in health economics.